Frequently Asked Questions

You may be a candidate if you're between 21 and 45 years old, have moderate to severe myopia with or without astigmatism, and a stable prescription. We use specialized imaging to confirm if EVO ICL is safe and effective for your anatomy. Even if you've been told you're not a LASIK candidate, EVO ICL may be the ideal solution.

EVO ICL (Implantable Collamer® Lens) is a biocompatible lens placed between your iris and natural lens that corrects vision without altering your cornea. Made from purified collagen, the lens works naturally to focus the light entering your eye. You won't see it or feel it, and neither will anyone else.

No. Numbing drops and light sedation ensure comfort throughout. Some patients note a bright light and slight pressure for a few seconds, but no pain. The treatment is quick and virtually painless.

Most patients notice dramatic improvement immediately after the procedure. Vision continues to stabilize over the first few days, with full clarity typically achieved within a week.

Yes, the lens is designed to last a lifetime. It can be removed or replaced by a surgeon if your vision changes or technology advances. This reversibility offers flexibility that laser procedures like LASIK cannot provide.

No. Unlike LASIK, EVO ICL does not disrupt corneal nerves or tear film production. It's ideal for patients with preexisting dry eye concerns or those seeking to avoid post-surgical dryness.

The cost of EVO ICL at Schorr Vision is typically around $9,000 for both eyes, reflecting the advanced technology and level of customization required for this procedure.

EVO ICL is different from laser vision correction. Instead of reshaping the cornea, a biocompatible lens is carefully placed inside the eye to correct vision with exceptional precision. That level of planning, sizing, and surgical expertise is what your investment supports.

At Schorr Vision, pricing is fully transparent. There are no hidden fees, no surprise charges, and no separate facility costs. Your procedure is performed in our private, in-office surgical suite for a more controlled and personalized experience.

Flexible monthly payment options, including interest-free financing, are available to make treatment more accessible.

For many patients, EVO ICL becomes an option after being told they are not a candidate for LASIK or other procedures.

If you have a higher prescription, dry eyes, or corneal limitations, EVO ICL offers a different approach. It works within the natural structure of your eye rather than removing tissue, which allows us to treat a wider range of patients safely and effectively.

Most people who choose EVO ICL are not looking for a quick fix. They are looking for a solution that finally fits.

Over time, the cost of glasses, specialty contact lenses, and ongoing prescriptions can add up significantly. EVO ICL can reduce or eliminate many of those long-term expenses while improving the quality of your vision.

If you are a good candidate, EVO ICL is designed to be a long-term solution. For many patients, it is the first time they feel like they have a real choice.

Yes. We offer flexible financing options, including interest-free plans, so you can move forward without unnecessary financial strain. During your consultation, we will walk you through your options and help you choose a plan that fits comfortably into your life.

For patients with high myopia, EVO ICL often provides superior visual outcomes compared to LASIK, including better night vision. A comprehensive evaluation determines which procedure is ideal for you. Both deliver exceptional results.

The FDA has approved EVO ICL for patients between 21 and 45 years old based on clinical safety studies. However, there are compelling reasons to consider EVO ICL for older patients, particularly those with high myopia. During your consultation, Dr. Schorr will assess whether you're a candidate based on your individual circumstances.